Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY 4.0Journal of Surgical Oncology

Routine MDM2 FISH Testing and Preoperative Biopsy Reduces Recurrence Rate of Atypical Lipomatous Tumours

  • Samuel O. H. Ching1
  • Anderson S. M. Leung2
  • Raymond C. H. Yau2
  • Albert Y. L. Lam2
  • Tony W. H. Shek1
  • Maximus C. F. Yeung1
  1. 1Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine, Queen Mary Hospital The University of Hong Kong Hong Kong SAR China
  2. 2Orthopaedic Oncology and Limb Salvage Surgery, Department of Orthopaedic and Traumatology Queen Mary Hospital Hong Kong SAR China
Read full textDOICite

Abstract

Background: Although MDM2 FISH test has been increasingly used to differentiate ALT and benign lipomatous tumours, its impact on clinical outcome remains underexplored. This study investigated whether routine MDM2 FISH testing on preoperative biopsy is associated with a reduction in the recurrence risk of ALT.

Methods: A total of 336 patients with MDM2‐verified well‐differentiated lipomatous tumours (ALT, n = 67; lipoma, n = 269) treated at a tertiary sarcoma centre were retrospectively analysed. Clinicopathological parameters, histological–molecular concordance, pre‐operative diagnostic approach and recurrence rates were compared.

Results: Compared to benign lipomatous tumours, ALT patients were older (p = 0.002), had larger tumours (median 15.0 vs 7.0 cm, p < 0.001) and more frequently deep extremity lesions (p < 0.001). Up to 25% of biopsy specimens of ALT exhibit purely benign morphology. ALT patients who underwent preoperative biopsy with MDM2 FISH had a lower recurrence rate than those who did not (16.2% vs 56.7%, p < 0.001). This was associated with a higher rate of extracapsular excision (97.3% vs 71.4%–77.8%, p = 0.021).

Conclusion: Routine MDM2 FISH testing on preoperative biopsy provides a definitive diagnosis of ALT, especially for lipoma‐like histology, enabling surgeons to plan extracapsular excision and thereby reducing local recurrence.

Related

  1. CT and MRI imaging features of atypical spindle cell lipomatous tumor in the retroperitoneum: a case report
    XueRong Li, Gang Li
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Recurrent angiolipoma-like atypical lipomatous tumour
    Joey Yan Leng Tan, Siang Shen Leon Foo, Kesavan Sittampalam
    Human Pathology ReportsPeer-reviewedCC BYFull textGeneral medicineDOAJ
  3. Giant hypervascular atypical lipomatous tumor/well-differentiated liposarcoma of the cervicodorsal region: a case report
    Zhonghai Liao, Feng Qin, Song Wang +2
    Frontiers in MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  4. Preoperative Zinc Deficiency as a Novel Prognostic Predictor for Postoperative Recurrence in Hepatocellular Carcinoma
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  5. High lesion detection rates with preoperative ⁹⁹ᵐTc-PSMA-SPECT/CT prior to radioguided surgery in biochemical recurrence: a hypothesis-generating analysis of quantitative PSMA-PET/CT parameters.
    Dominic Ufton, Jan Heilinger, David Pfister +3
    EJNMMI researchPeer-reviewedCC BYFull textMedical imaging & radiologyEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{ching2026routine,
  title = {{Routine MDM2 FISH Testing and Preoperative Biopsy Reduces Recurrence Rate of Atypical Lipomatous Tumours}},
  author = {Samuel O. H. Ching and Anderson S. M. Leung and Raymond C. H. Yau and Albert Y. L. Lam and Tony W. H. Shek and Maximus C. F. Yeung},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  month = jul,
  doi = {10.1002/jso.70349},
  url = {https://doi.org/10.1002/jso.70349},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Routine MDM2 FISH Testing and Preoperative Biopsy Reduces Recurrence Rate of Atypical Lipomatous Tumours
AU  - Samuel O. H. Ching
AU  - Anderson S. M. Leung
AU  - Raymond C. H. Yau
AU  - Albert Y. L. Lam
AU  - Tony W. H. Shek
AU  - Maximus C. F. Yeung
PY  - 2026
DA  - 2026/07/29
JO  - Journal of Surgical Oncology
DO  - 10.1002/jso.70349
UR  - https://doi.org/10.1002/jso.70349
AB  - Background: Although MDM2 FISH test has been increasingly used to differentiate ALT and benign lipomatous tumours, its impact on clinical outcome remains underexplored. This study investigated whether routine MDM2 FISH testing on preoperative biopsy is associated with a reduction in the recurrence risk of ALT.  Methods: A total of 336 patients with MDM2‐verified well‐differentiated lipomatous tumours (ALT, n = 67; lipoma, n = 269) treated at a tertiary sarcoma centre were retrospectively analysed. Clinicopathological parameters, histological–molecular concordance, pre‐operative diagnostic approach and recurrence rates were compared.  Results: Compared to benign lipomatous tumours, ALT patients were older (p = 0.002), had larger tumours (median 15.0 vs 7.0 cm, p < 0.001) and more frequently deep extremity lesions (p < 0.001). Up to 25% of biopsy specimens of ALT exhibit purely benign morphology. ALT patients who underwent preoperative biopsy with MDM2 FISH had a lower recurrence rate than those who did not (16.2% vs 56.7%, p < 0.001). This was associated with a higher rate of extracapsular excision (97.3% vs 71.4%–77.8%, p = 0.021).  Conclusion: Routine MDM2 FISH testing on preoperative biopsy provides a definitive diagnosis of ALT, especially for lipoma‐like histology, enabling surgeons to plan extracapsular excision and thereby reducing local recurrence.
SN  - 0022-4790
SN  - 1096-9098
ER  -